Intravenous infusion of diarginylinsulin, an insulin analogue: Effects on glucose turnover and lipid levels in insulin-treated type II diabetic patients
- 31 May 1992
- journal article
- Published by Elsevier in Metabolism
- Vol. 41 (5) , 540-544
- https://doi.org/10.1016/0026-0495(92)90215-v
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Recombinant DNA derived monomeric insulin analogue: comparison with soluble human insulin in normal subjects.BMJ, 1988
- Monomeric insulins obtained by protein engineering and their medical implicationsNature, 1988
- Basal and 24-h C-peptide and insulin secretion rate in normal manDiabetologia, 1987
- NEW TACTICS FOR TYPE 2 DIABETES: REGIMENS BASED ON INTERMEDIATE-ACTING INSULIN TAKEN AT BEDTIMEThe Lancet, 1985
- Interval between insulin injection and eating in relation to blood glucose control in adult diabetics.BMJ, 1985
- The “Dawn Phenomenon” — A Common Occurrence in Both Non-Insulin-Dependent and Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1984
- Examination of the role of the pituitary-adrenocortical axis, counterregulatory hormones, and insulin clearance in variable nocturnal insulin requirements in insulin-dependent diabetesDiabetes, 1983
- Intermediate acting insulin given at bedtime: effect on blood glucose concentrations before and after breakfast.BMJ, 1983
- Timing of pre-breakfast insulin injection and postprandial metabolic control in diabetic childrenBMJ, 1980
- Overnight basal insulin requirements in fasting insulin-dependent diabeticsDiabetes, 1980